726 related articles for article (PubMed ID: 20650501)
1. Outcome of antibiotic prophylaxis discontinuation in patients with persistent vesicoureteral reflux initially presenting with febrile urinary tract infection: time to event analysis.
Leslie B; Moore K; Salle JL; Khoury AE; Cook A; Braga LH; Bägli DJ; Lorenzo AJ
J Urol; 2010 Sep; 184(3):1093-8. PubMed ID: 20650501
[TBL] [Abstract][Full Text] [Related]
2. Early discontinuation of antibiotic prophylaxis in patients with persistent primary vesicoureteral reflux initially detected during infancy: outcome analysis and risk factors for febrile urinary tract infection.
Moriya K; Mitsui T; Kitta T; Nakamura M; Kanno Y; Kon M; Nishimura Y; Shinohara N; Nonomura K
J Urol; 2015 Feb; 193(2):637-42. PubMed ID: 25111912
[TBL] [Abstract][Full Text] [Related]
3. Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux.
Kitchens DM; Herndon A; Joseph DB
J Urol; 2010 Oct; 184(4 Suppl):1594-7. PubMed ID: 20728116
[TBL] [Abstract][Full Text] [Related]
4. Predicting early recurrent urinary tract infection in pretoilet trained children with vesicoureteral reflux.
Yamazaki Y; Shiroyanagi Y; Matsuno D; Nishi M
J Urol; 2009 Oct; 182(4 Suppl):1699-702. PubMed ID: 19692080
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
6. The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux.
Cooper CS; Chung BI; Kirsch AJ; Canning DA; Snyder HM
J Urol; 2000 Jan; 163(1):269-72; discussion 272-3. PubMed ID: 10604374
[TBL] [Abstract][Full Text] [Related]
7. Febrile urinary tract infection after ureteroneocystostomy: a contemporary assessment at a single institution.
Whittam BM; Thomasch JR; Makari JH; Tanaka ST; Thomas JC; Pope JC; Adams MC; Brock JW
J Urol; 2010 Feb; 183(2):688-92. PubMed ID: 20022039
[TBL] [Abstract][Full Text] [Related]
8. Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux.
Thompson RH; Chen JJ; Pugach J; Naseer S; Steinhardt GF
J Urol; 2001 Oct; 166(4):1465-9. PubMed ID: 11547114
[TBL] [Abstract][Full Text] [Related]
9. High grade primary vesicoureteral reflux in boys: long-term results of a prospective cohort study.
Alsaywid BS; Saleh H; Deshpande A; Howman-Giles R; Smith GH
J Urol; 2010 Oct; 184(4 Suppl):1598-603. PubMed ID: 20728178
[TBL] [Abstract][Full Text] [Related]
10. The Swedish reflux trial in children: III. Urinary tract infection pattern.
Brandström P; Esbjörner E; Herthelius M; Swerkersson S; Jodal U; Hansson S
J Urol; 2010 Jul; 184(1):286-91. PubMed ID: 20488494
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of grades III and IV primary vesicoureteral reflux in children with and without acute pyelonephritis as breakthrough infections: a comparative analysis.
Yu TJ; Chen WF
J Urol; 1997 Apr; 157(4):1404-6. PubMed ID: 9120964
[TBL] [Abstract][Full Text] [Related]
12. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children.
Swerkersson S; Jodal U; Sixt R; Stokland E; Hansson S
J Urol; 2007 Aug; 178(2):647-51; discussion 650-1. PubMed ID: 17574623
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial.
Montini G; Rigon L; Zucchetta P; Fregonese F; Toffolo A; Gobber D; Cecchin D; Pavanello L; Molinari PP; Maschio F; Zanchetta S; Cassar W; Casadio L; Crivellaro C; Fortunati P; Corsini A; Calderan A; Comacchio S; Tommasi L; Hewitt IK; Da Dalt L; Zacchello G; Dall'Amico R;
Pediatrics; 2008 Nov; 122(5):1064-71. PubMed ID: 18977988
[TBL] [Abstract][Full Text] [Related]
14. Observation of patients with vesicoureteral reflux off antibiotic prophylaxis: physician bias on patient selection and risk factors for recurrent febrile urinary tract infection.
Drzewiecki BA; Thomas JC; Pope JC; Adams MC; Brock JW; Tanaka ST
J Urol; 2012 Oct; 188(4 Suppl):1480-4. PubMed ID: 22906676
[TBL] [Abstract][Full Text] [Related]
15. Bladder dynamics and vesicoureteral reflux: factors associated with idiopathic lower urinary tract dysfunction in children.
Ural Z; Ulman I; Avanoglu A
J Urol; 2008 Apr; 179(4):1564-7. PubMed ID: 18295262
[TBL] [Abstract][Full Text] [Related]
16. Bladder volume at onset of vesicoureteral reflux is an independent risk factor for breakthrough febrile urinary tract infection.
Alexander SE; Arlen AM; Storm DW; Kieran K; Cooper CS
J Urol; 2015 Apr; 193(4):1342-6. PubMed ID: 25305355
[TBL] [Abstract][Full Text] [Related]
17. The impact of treated dysfunctional voiding on the nonsurgical management of vesicoureteral reflux.
Snodgrass W
J Urol; 1998 Nov; 160(5):1823-5. PubMed ID: 9783967
[TBL] [Abstract][Full Text] [Related]
18. Changing concepts concerning the management of vesicoureteral reflux.
Herndon CD; DeCambre M; McKenna PH
J Urol; 2001 Oct; 166(4):1439-43. PubMed ID: 11547107
[TBL] [Abstract][Full Text] [Related]
19. Redo ureteroneocystostomy using an extravesical approach in pediatric renal transplant patients with reflux: a retrospective analysis and description of technique.
Krishnan A; Swana H; Mathias R; Baskin LS
J Urol; 2006 Oct; 176(4 Pt 1):1582-7; discussion 1587. PubMed ID: 16952692
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic prophylaxis for urinary tract infections in children with spina bifida on intermittent catheterization.
Zegers B; Uiterwaal C; Kimpen J; van Gool J; de Jong T; Winkler-Seinstra P; Houterman S; Verpoorten C; de Jong-de Vos van Steenwijk C
J Urol; 2011 Dec; 186(6):2365-70. PubMed ID: 22019031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
